CASP4 and non-small cell lung carcinoma: Moreover, ROC curve showed that the AUC was 0.7273, implying that, although at lower levels than the plasma, tissue levels of caspase-4 tested by means of ELISA could represent a novel diagnostic tissue biomarker for NSCLC patients (Figure 4D).